Viseven

NOVEMBER 9, 2022

Key Opinion Leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. However, given the current regulatory approval challenges, many pharma companies seek to collaborate with KOLs medical throughout the entire drug development cycle.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Viseven

DECEMBER 13, 2024

Patient recruitment often required participants to travel to trial sites, like hospitals or research centers, creating barriers due to geographic distance, travel costs, and time away from daily obligations. This restricted participation, limiting accessibility and diversity within trials. This improves compliance and fosters collaboration.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Documentation Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 28, 2022

This decreases the need for hospital visits and related costs, freeing up vital time and resources for doctors and nurses to treat patients most in need. Furthermore, monitoring patients when they come out of hospital helps to avoid any relapses or readmissions, effectively providing a safety net. “A Free Whitepaper.

Hospitals 52

Hospitals Packaging Medical Schools Documentation 52

Putting Patients First Blog

MAY 29, 2024

We believe in the power of high-quality patient engagement that is characterized by sustained, reciprocal communication between patients and decision- makers. The NHC urges CMS to engage collaboratively with MA plans to track the clarity, accuracy, and transparency of marketing materials and communications. hstc=117268889.c6acac5669d4f1e6063a774e6d96c6b5.1716560813145.1716560813145.1716560813145.1&

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Prescription Filling Hospitals 52

pharmaphorum

MARCH 30, 2021

For example, the company recently launched Rare Answers , a system of innovative and sustainable tools that are designed to help shorten the diagnostic journey for children with a rare disease – developed in collaboration with leading children’s hospitals and technology and data science companies. Rare diseases during COVID.

Hospitals 111

Hospitals Communication Drug Development Pharmaceutical Companies 111

pharmaphorum

SEPTEMBER 6, 2021

Furthermore, EHR vendors have been sued for selling non-functioning products to hospitals and accused of acts of fraud , and although EHRs improved safety in some areas, they also introduce new risks systemic in nature. There are various ways that a system like this could potentially be implemented in hospitals and doctors’ offices worldwide.

Medical Records 145

Medical Records Health and Personal Care Stores Data Entry Hospitals 145

pharmaphorum

MAY 27, 2022

Teams and Zoom became the backbone of communication and firms embraced new ways of working. within homes or within community hubs) – could potentially help reach more participants in rural communities or those who are not able or willing to regularly visit a traditional study site such as a general hospital.

Packaging 80

Packaging Generic Medicine Communication Hospitals 80

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

OCTOBER 28, 2020

Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. In the UK, for example, every NHS hospital has a ‘patient panel’ made up of service users. The omission of medicines from the feedback revolution is curious and potentially damaging.

Vaccines 120

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 120

pharmaphorum

SEPTEMBER 9, 2021

Public health agencies and pharma pivoted in countless ways, from decentralising clinical trials and accelerating research and development, to enabling remote care and remote working with rapid digitisation. And we transformed so quickly because the key players communicated and collaborated.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. We talk a lot in clinical trials and drug development about benefit,” Dr Mullen said. But who is benefitting?

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 111

Viseven

SEPTEMBER 18, 2024

When COVID hit, the urgent need to accelerate drug development meant shrinking timelines from years to months, with no room for compromises on quality. Cloud computing facilitates effortless collaboration Cloud computing makes it easier for life sciences companies to communicate and collaborate globally.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

APRIL 3, 2023

The results also showed a reduction in risk of hospitalization for any cause with 14% relative risk reduction (24.8 in pre-specified 2EPs while the reductions in other 2EPs of hospitalization for HF or CV death or all-cause death were not statistically significant The safety data were consistent with the prior safety profile of Jardiance.

Biosimilars 40

Biosimilars Diabetes Compounding Hospitals 40

Express Pharma

OCTOBER 31, 2024

She highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to harnessing India’s vast talent pool, particularly in the scientific and medical fields, in an interview with Viveka Roychowdhury India seems to have become a hub for pharma GCCs. With a long gestation period.

Drug Development 105

Drug Development Hospitals Process Improvement Documentation 105